EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease

Enes Akyuz iD, Feyza Sule Aslan iD, Enise Gokce iD, Oguzkan Ilmaz iD, Feyzullah Topcu iD, Seda Kakac iD

European Journal of Neuroscience · 2024

DOI: 10.1111/ejn.16541 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Enes Akyuz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, International School of Medicine, University of Health Sciences, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Genetic Therapy, Extracellular Vesicles, CRISPR-Cas Systems, Huntington Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are characterized by progressive deterioration of the nervous system. Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD) are prominently life‐threatening examples of neurodegenerative diseases. The complexity of the pathophysiology in neurodegenerative diseases causes difficulties in diagnosing. Although the drugs temporarily help to correct specific symptoms including memory loss and degeneration, a complete treatment has not been found yet. New therapeutic approaches have been developed to understand and treat the underlying pathogenesis of neurodegenerative diseases. With this purpose, clustered‐regularly interspaced short palindromic repeats/CRISPR‐associated protein (CRISPR/Cas) technology has recently suggested a new treatment option. Editing of the genome is carried out by insertion and deletion processes on DNA. Safe delivery of the CRISPR/Cas system to the targeted cells without affecting surrounding cells is frequently investigated. Extracellular vesicles (EVs), that is exosomes, have recently been used in CRISPR/Cas studies. In this review, CRISPR/Cas and EV approaches used for diagnosis and/or treatment in AD, PD, ALS, and HD are reviewed. CRISPR/Cas and EV technologies, which stand out as new therapeutic approaches, may offer a definitive treatment option in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyExtracellular VesiclesCRISPR-Cas SystemsHuntington DiseaseAmyotrophic Lateral SclerosisParkinson DiseaseAlzheimer DiseaseHumansAnimalsGene EditingNeurodegenerative Diseases

Stichwörter der Autor:innen

biomarkerexosome technologygenome editingneurodegenerative diseases

Autor:innen und Institutionen

  • Department of Biophysics, International School of Medicine, University of Health Sciences, Istanbul, Türkiye.
  • School of Medicine, Marmara University, Istanbul, Türkiye.
  • School of Medicine, Pamukkale University, Denizli, Türkiye.
  • School of Medicine, Giresun University, Giresun, Türkiye.
  • Department of Molecular Biology and Genetics, Faculty of Science, Gebze Technical University, Kocaeli, Türkiye.

ORCID-Profile: Enes Akyuz, Feyza Sule Aslan, Enise Gokce, Oguzkan Ilmaz, Feyzullah Topcu, Seda Kakac

Zitieren

APA

Akyuz, E., Aslan, F. S., Gokce, E., Ilmaz, O., Topcu, F., & Kakac, S. (2024). Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16541

Vancouver

Akyuz E, Aslan FS, Gokce E, Ilmaz O, Topcu F, Kakac S. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16541

BibTeX
@article{Akyuz2024,
  author = {Akyuz, Enes and Aslan, Feyza Sule and Gokce, Enise and Ilmaz, Oguzkan and Topcu, Feyzullah and Kakac, Seda},
  title = {Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease},
  journal = {European Journal of Neuroscience},
  year = {2024},
  doi = {10.1111/ejn.16541}
}
Kostenlos starten →